Advertisement

Update 1987 pp 12-15 | Cite as

Abnormal Metabolic Control in Septic Multiple Organ Failure

  • J. H. Siegel
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 3)

Abstract

The usual characterization of sepsis is that it is a disease process caused by infectious organisms. However, recent evidence suggests that sepsis is rather an acquired disease of intermediary metabolism induced by the host response to invasion by infectious agents.The characteristics and the magnitude of this metabolic disorder are not specific for particular infectious agents, but occur with bacterial, fungal and viral organisms. The metabolic dysfunction which is initiated by sepsis induces a shift in the pattern of physiologic abnormalities and dynamic metabolic interrelations which are involved in the regulation of energetic substrate flux between skeletal muscle, liver and adipose tissue. This altered regulation modifies the normal balance of control by neuro and endocrine mechanisms.

Keywords

Hyperdynamic State Muscle Proteolysis Septic Process Organ Clearance Septic Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Siegel JH, Cerra FB, Coleman B, et al (1979) Physiological and metabolic correlations in human sepsis. Surgery 86(2):163–193PubMedGoogle Scholar
  2. 2.
    Siegel JH, Giovannini I, Coleman B (1979) Ventilation: perfusion maldistribution secondary to the hyperdynamic cardiovascular state as the major cause of increased pulmonary shunting in human sepsis. J Trauma 19(6):432–460PubMedCrossRefGoogle Scholar
  3. 3.
    Siegel JH, Giovannini I, Coleman B, Cerra FB, Nespoli A (1982) Pathologic synergy modulation of the cardiovascular, respiratory and metabolic response to injury by cirrhosis and/or sepsis: a manifestation of a common metabolic defect? Arch Surg 117:225–238PubMedCrossRefGoogle Scholar
  4. 4.
    Sganga G, Siegel JH, Brown G, et al (1985) Reprioritization of hepatic plasma protein release in trauma and sepsis. Arch Surg 120:187–199PubMedCrossRefGoogle Scholar
  5. 5.
    Pittiruti M, Siegel JH, Sganga G, et al (1985) Increased dependence of leucine in post-traumatic sepsis: leucine/tyrosine clearance ratio as indicator of hepatic impairment in septic multiple organ failure syndrome. Surgery 98(3):378–387PubMedGoogle Scholar
  6. 6.
    Vary T, Siegel JH, Nakatani T, Sato T, Aoyama H (1986) Regulation of glucose metabolism by altered pyruvate dehydrogenase activity I. Potential site of insulin resistance in sepsis JPEN 10(4):351–355Google Scholar
  7. 7.
    Vary TC, Siegel JH, Nakatani T, Sato T, Aoyama H (1986) A biochemical basis for depressed ketogenesis in sepsis. J Trauma 26:419–425PubMedCrossRefGoogle Scholar
  8. 8.
    Siegel JH, Vary TC (1987) Sepsis, abnormal metabolic control and the multiple organ failure syndrome. In: Siegel JH (ed) Trauma: Emergency Surgery and Critical Care. Churchill-Livingstone, New York, pp 411–501Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • J. H. Siegel

There are no affiliations available

Personalised recommendations